The management of streptococcal and enterococcal endocarditis has chan
ged in recent years with the development of effective new regimens tha
t are easier to administer, but resistance to commonly used antibiotic
s has appeared, especially among enterococci. Beta-lactam antibiotics
either alone or in combination are suitable for most patients with vir
idans streptococci. Streptococci bovis, and S. pneumoniae, but alterna
tive regimens are necessary for special situations. Group B, C and G s
treptococci respond best to the combination of a penicillin and an ami
noglycoside. Enterococci are relatively resistant to penicillins and c
ephalosporins and strains resistant to beta-lactams, glycopeptides and
aminoglycosides have become more common lately. Strategies are propos
ed dependent on the resistance of the organisms, but it is recognized
that medical failure is not uncommon and surgical removal of the infec
ted valve may be the only curative treatment.